ENGN · smart money activity

Who's buying enGene Therapeutics Inc.?

enGene Therapeutics Inc. has 1 recent smart-money filing on record (13F), the latest on Aug 14, 2026.

Smart money score Score and rank in Pro

Latest filingAug 14, 2026

Independent buyers1

Signal sources13F

Insiders' avg buy price Pro

ENGN insider buying, 13F and 13D filings

Filed Aug 14, 2026New 13F stake

Perceptive Advisors: New position: 4.82M sh (~$8.3M, 0.1% of book)

View the filing on SEC EDGAR ↗

ENGN's score and rank are in Pro, with alerts when the next filing lands.

Try Pro free for 7 days

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.